NFKB1 and cancer: Furthermore, our GSEA results from RNA sequencing showed statistically significant differences in the Nod-like receptor signaling pathway, RIG-I-like receptor signaling pathway, NF-κB signaling pathway, hematopoietic cell lineage, and transcriptional misregulation in cancer and inflammatory bowel disease (Fig. 4A).